【摘 要】
：
Objectives: AP611074 is a new drug that inhibits the interaction of E1/E2 proteins of HPV6/11, blocking HPV replication.We aimed to obtain proof-of-concept of AP611074 in the topical treatment of cond
【机 构】
：
Hospital de Clinicas-UBA and IADT,Buenos Aires De
【出 处】
：
The 6th Biennial Conference of Asia Oceania Research Organis
论文部分内容阅读
Objectives: AP611074 is a new drug that inhibits the interaction of E1/E2 proteins of HPV6/11, blocking HPV replication.We aimed to obtain proof-of-concept of AP611074 in the topical treatment of condyloma caused by HPV6/11 infection.
其他文献
Whether in clinical trials, prospective cohort studies, or routine screening programs, too many individuals are categorized as "lost to follow-up".How can we prevent the "loss" of these people?
Using science to inform decision making ensures that policies and practices used in the prevention, detection, and treatment of diseases are based on data, principles, and findings.
Objective: To develop and implement a community based model for cervical cancer prevention that allows the communities to manage the screening and the healthcare system to focus resources on evaluatio
El Salvador has one of the worlds highest cervical cancer incidence and mortality rates.To improve cervical cancer screening, the Ministry of Health (MOH), in cooperation with Basic Health Internation
Although HPV vaccination will likely be the ultimate cervical cancer prevention strategy,given its effectiveness, the worldwide familiarity and acceptance of vaccination as a preventive strategy, and
Arbor Vita Corporation, in collaboration with PATH and CICAMS, developed the OncoE6TM Cervical Test ("E6 Test") for settings where ease of test use, short time from sample collection to result, and a
The knowledge that cervical neoplasia are caused by persistent infection with one of the high-risk types of human papilloma virus types and around 70％ cervical cancers are caused by HPV 16 or HPV 18 p
Objectives:To describe the experience on scaling up of VIA screening and to assess the diagnosis and management for pre-cancer at BSMMU.
Cervical cancer rates are slowly declining in India and it is now the second most common cancer among women.
Preinvasive neoplasia of the vulva has been recognized for over 90 years, but terminology to describe this disease has been confusing.